Xianju Pharmaceutical disclosed its semi-annual report on August 27. The company achieved operating income of 1,959 million yuan in the first half of the year, an increase of 4.78%; net profit attributable to shareholders of listed companies was 245 million yuan, a year-on-year decrease of 20.67%; and basic earnings per share were 0.2472 yuan. The company plans to distribute a cash dividend of 1 yuan for every 10 shares to all shareholders.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.